Elanco Animal Health (ELAN) support and resistance · rev $2.74B
Elanco Animal Health (ELAN) is a drug manufacturers - specialty & generic company listed on US.
This page maps Elanco Animal Health (ELAN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ELAN revenue for 2026-06-30 was $2.74B. Net income was $111.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. ELAN currently screens at market cap $11.80B.
ELAN currently screens at market cap $11.80B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ELAN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ELAN quote page for the session range and the stock page for the full model.
Not investment advice.